ClinicalTrials.Veeva

Menu

AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care

S

SingHealth Community Hospitals

Status

Not yet enrolling

Conditions

Rehabilitation
Deconditioning

Treatments

Device: Rebee

Study type

Interventional

Funder types

Other

Identifiers

NCT06683963
20242246

Details and patient eligibility

About

The study team proposes ATLAS (AI-Assisted TelerehabiLitAtion System) a two-part solution. The first-Rebee AI-assisted telerehabilitation device-assists in inpatient rehabilitation, and allows patients to continue with their physical rehabilitation when discharged and waiting for Day Rehabilitation Centre (DRC). The second-a structured programme to train and familiarise patients and caregivers to Rebee over patients' Community Hospital (CH) inpatient rehabilitation stay-adopts an evidence-based approach to increase uptake and adherence to Rebee.

Enrollment

450 estimated patients

Sex

All

Ages

60 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Rehabilitation Diagnostic Group (RDG): Total Knee Replacement / Deconditioning
  2. Age 60 and above
  3. Speak English/Mandarin
  4. Able to follow instructions, no cognitive impairment
  5. No MDRO (MultiDrug Resistant Organism)
  6. Suitable and able to wear motion sensor on upper and lower limbs
  7. Suitable and able to engage in Rebee exercises

Exclusion criteria

  1. Not under RDG: Total Knee Replacement / Deconditioning
  2. Below 60 years old
  3. Unable to speak English/Mandarin
  4. Cognitive impaired, unable to follow instructions
  5. Has MDRO
  6. Not suitable to wear motion sensor on upper and lower limbs
  7. Refusal to participate / give informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

450 participants in 2 patient groups

Control - usual care
No Intervention group
Description:
Business as usual in community hospital, no added device intervention
Intervention - Rebee
Experimental group
Description:
Addition of Rebee device during and after community hospital stay
Treatment:
Device: Rebee

Trial contacts and locations

0

Loading...

Central trial contact

Lian Leng Low; Charmaine Tan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems